LAVA Therapeutics N.V. (LVTX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts LVTX Hot Sheet
Join SI Premium – FREE
LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- MSCI upgrades Bulgaria to Frontier, flags Indonesia and Turkey risks
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
